TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nutrivision Research and Development Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
465
|
234
|
508 |
| Financial expenses |
0
|
21
|
0 |
| Earnings before taxes |
164
|
-68
|
36 |
| EBITDA |
43
|
-99
|
-33 |
| Total assets |
3,893
|
3,677
|
3,489 |
| Current assets |
3,404
|
3,193
|
3,061 |
| Current liabilities |
26
|
17
|
31 |
| Equity capital |
3,372
|
3,177
|
3,025 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
86.6%
|
86.4%
|
86.7% |
| Turnover per employee |
465
|
234
|
508 |
| Profit as a percentage of turnover |
35.3%
|
-29.1%
|
7.1% |
| Return on assets (ROA) |
4.2%
|
-1.3%
|
1.0% |
| Current ratio |
13092.3%
|
18782.4%
|
9874.2% |
| Return on equity (ROE) |
4.9%
|
-2.1%
|
1.2% |
| Change turnover |
227
|
-310
|
-64 |
| Change turnover % |
95%
|
-57%
|
-11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.